TV News LIES

Friday, May 27th

Last update05:20:13 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


96-year-old Heimlich uses namesake maneuver on choking woman

Henry HeimlichThe 96-year-old Cincinnati surgeon credited with developing his namesake Heimlich maneuver recently used the emergency technique...

BMX Legend Dave Mirra Had CTE When He Died

Dave MirraBMX icon Dave Mirra, who died in February, suffered from the type of chronic brain damage...

Cell phone radiation may cause cancer, new government study finds

Cell phone use may cause cancerIt’s the news everyone has been dreading: That little cell phone that people use all the...

Family of Tony Gwynn files wrongful death lawsuit against tobacco industry

Tony Gwynn The family of Hall of Fame baseball player Tony Gwynn has filed a wrongful death lawsuit...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!